Home › Cancro della testa e del collo › Massachusetts › Boston
Studi clinici su Cancro della testa e del collo a Boston, MA
22 studi su Cancro della testa e del collo cercano partecipanti presso sedi a Boston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
In reclutamentoFase 2/3
- Site #0131, Boston
- Site#0101, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
In reclutamento
- Dana-Farber Cancer Institute, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
In reclutamentoFase 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Toripalimab With Chemotherapy for Sinus Cancer
In reclutamentoFase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC
In reclutamentoFase 2
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Massachusetts General Hospital Cancer Center, Boston
Jump: MR Simulation For Radiation Therapy Master Protocol
In reclutamento
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
PDT For Induction Therapy For Head And Neck Cancer
In reclutamentoFase 2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
In reclutamentoStudio osservazionale
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
In reclutamentoFase 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
In reclutamentoFase 1/2
- Massachusetts General Hospital,, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
In reclutamento
- Dana Farber Cancer Institute, Boston
Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy
In reclutamento
- Brigham and Women's Hospital, Boston
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
In reclutamentoFase 1 iniziale
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
In reclutamentoFase 1/2
- Dana Farber Cancer Institute, Boston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
In reclutamentoFase 1
- Dana Farber/Partners Cancer Care Inc, Boston
Comprehensive Outcomes for After Cancer Health
In reclutamentoVolontari sani benvenuti
- Dana Farber Cancer Institute, Boston
Studi su Cancro della testa e del collo in altre città
- Houston, TX30 studi
- New York City, NY21 studi
- Nashville, TN21 studi
- St. Louis, MO15 studi
- Dallas, TX12 studi
- Pittsburgh, PA11 studi
- Los Angeles, CA10 studi
- San Antonio, TX10 studi
- Baltimore, MD10 studi
- Washington, DC10 studi
- Durham, NC10 studi
- Chicago, IL10 studi
Altri studi a Boston
- Cancro al seno112 studi
- Cancro del polmone non a piccole cellule90 studi
- Cancro (tutti i tipi)85 studi
- Cancro metastatico63 studi
- Cancro colorettale63 studi
- Cancro ai polmoni62 studi
- Cancro ovarico61 studi
- Cancro alla prostata59 studi
- Depressione52 studi
- Cancro dell'endometrio50 studi
- Insufficienza cardiaca44 studi
- Leucemia mieloide acuta44 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.